| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.21B | +4.9% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.05B | +2.5% |
| Gross margin | 37.4% | Net margin 22.4% |
| Revenue Q/Q | -10.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 62.6% |
| R&D | ¥0.02B | 7.3% |
| SG&A | ¥0.02B | 8.4% |
| Tax & other | ¥0.01B | 2.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
大宏立 ・ 圣元环保 ・ 杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies